A discovery made by researchers at Binghamton University, State University of New York, could lead to new ways of treating chronic infections. They have identified three key regulators required for the formation and development of biofilms.
Biofilms — communities of bacteria in self-produced slime — may be found almost anywhere that solids and liquids meet, whether in nature, in hospitals or in industrial settings. Biofilms are implicated in more than 80 percent of chronic inflammatory and infectious diseases caused by bacteria, including ear infections, gastrointestinal ulcers, urinary tract infections and pulmonary infections in cystic fibrosis patients, according to the Centers for Disease Control.
Immune Response Suppressed in Chronic Infections by Targeting Stromal Cells
A team of scientists at Emory have observed based on a study in mice that chronic viral infections evade the immune response by targeting the stromal cells.
A team of scientists at Emory have observed based on a study in mice that chronic viral infections evade the immune response by targeting the stromal cells.
Source-Eurekalert
TAN
Key to Strengthening Immune Response to Chronic Infection Identified by Wistar Scientists
A protein that could serve as a target for reprogramming immune system cells exhausted by exposure to chronic viral infection to be more effective against certain viruses like HIV has been identified
A protein that could serve as a target for reprogramming immune system cells exhausted by exposure to chronic viral infection to be more effective against certain viruses like HIV has been identified
Risk of Chronic Infections High Among Poor Kids
Children who belong to poor families carry an increased risk of suffering from chronic infections, according to two recent studies from the University of Michigan.
Children who belong to poor families carry an increased risk of suffering from chronic infections, according to two recent studies from the University of Michigan.
New Treatment for Hepatitis C Holds Promise
An experimental treatment targeting hepatitis C was able to inhibit replication of the virus in the bloodstream of chimpanzees and could treat chronic infections in humans, a new study said Thursday.
An experimental treatment targeting hepatitis C was able to inhibit replication of the virus in the bloodstream of chimpanzees and could treat chronic infections in humans, a new study said Thursday.
